
Neolook Solutions is a specialized independent spin-out from Royal Philips focused on neonatal and pediatric intensive care. The company develops and markets video augmented services and smart sensor devices designed to support family bonding, clinical understanding, and research in NICUs and PICUs. Their key products include S2S Family for remote family connection, S2S Professional for clinical use with system integrations, S2S Academic for research and AI development, and the Neolook One smart device. Neolook operates a scalable service model with a strong emphasis on privacy, clinical collaboration, and innovation, serving customers globally with local partners. The company has achieved national leadership in the Netherlands, CE MDR certification, and international accelerator recognition, positioning it well for expansion in Europe, the Middle East, and the U.S.

Neolook Solutions is a specialized independent spin-out from Royal Philips focused on neonatal and pediatric intensive care. The company develops and markets video augmented services and smart sensor devices designed to support family bonding, clinical understanding, and research in NICUs and PICUs. Their key products include S2S Family for remote family connection, S2S Professional for clinical use with system integrations, S2S Academic for research and AI development, and the Neolook One smart device. Neolook operates a scalable service model with a strong emphasis on privacy, clinical collaboration, and innovation, serving customers globally with local partners. The company has achieved national leadership in the Netherlands, CE MDR certification, and international accelerator recognition, positioning it well for expansion in Europe, the Middle East, and the U.S.
Founded: 2020 (spin-out from Royal Philips)
Headquarters: Utrecht, The Netherlands
Focus: Video-augmented services, clinical AI and biosensing for NICU/PICU
Flagship products: S2S Family, S2S Professional, S2S Academic, Neolook One
Certification: CE MDR
Employees (approx.): 15
Neonatal and pediatric intensive care — improving family engagement, clinical monitoring, and research capabilities in NICU/PICU settings.
2020
Healthtech / Medical devices and clinical software
Seed round recorded on Apr 1, 2021; public profiles obfuscate the raised amount. Dealroom lists activity in 2021 with a Dec 2021 seed entry and a reported valuation (EUR 4.3M) in some profiles.